Director/PDMR Shareholding

RNS Number : 0261J

Advanced Medical Solutions Grp PLC

23 March 2010

 



 

Advanced Medical Solutions Group plc

("AMS" or the "Group")

Exercise of share options and Directors' dealings

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company, today announces that following the successful achievement of certain performance criteria and the release of the recent preliminary results statement, the following options from certain share incentive schemes have been exercised as outlined below,

In order to cover the exercise cost and the tax payable on this exercise the directors have sold ordinary shares of 5p each on 22 March 2010 as detailed below.

Long Term Incentive Plan (LTIP)

Director	No. of LTIPs prior to exercise	LTIPs exercised	LTIPs after exercise
Don Evans CEO	3,295,016	3,001,173	293,843
Chris Meredith COO	1,797,234	1,208,000	589,234
Mary Tavener FD	2,407,979	2,214,571	193,408

Deferred Share Bonus Plan (DSB)

Director	No. of DSBs prior to exercise	DSBs exercised	DSBs after exercise
Don Evans CEO	218,997	90,410	128,587
Chris Meredith COO	135,130	49,313	85,827
Mary Tavener FD	194,147	90,410	103,737

Unapproved Executive Share Option Scheme

Director	No. of options prior to exercise	Options exercised	Options after exercise
Don Evans CEO	616,666	616,666	0
Mary Tavener FD	300,000	300,000	0

Directors' Dealings in shares

Director	Holding prior to exercise	Holding following exercise	Number of shares sold	Sale price (p)	Resultant holding	% of issued share capital
Don Evans CEO	869,591	4,577,840	1,394,125	35.00	3,183,715	2.1
Chris Meredith COO	74,538	1,331,851	229,962	35.00	1,101,889	0.7
Mary Tavener FD	246,130	2,851,111	782,070	35.00	2,069,041	1.3

For further information, please contact:

Advanced Medical Solutions Group plc
Don Evans, Chief Executive Officer Mary Tavener, Finance Director Chris Meredith, Chief Operating Officer www.admedsol.com	Tel: [phone]
Tavistock Communications	Tel: [phone]
John West / Chris Munden
Investec Bank plc	Tel: [phone]
Gary Clarence / Daniel Adams

Notes to Editors:

Advanced Medical Solutions develops and manufactures products for the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative products for advanced woundcare and wound closure. 

The advanced woundcare products are based on the moist wound healing principle.  AMS uses its in-house technology to provide a vertically integrated 'one stop shop' for all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.

AMS' technology in cyanoacrylate based tissue adhesives is used for the closure of small cuts and trauma wounds through to large surgical incisions, and also for protecting or sealing skin to prevent breakdown or infection.

AMS' products which currently serve the majority of the key global markets are sold either direct or through strategic partners and distributors.

 

END

 

 

RDSBDGDXGBDBGGX